124 related articles for article (PubMed ID: 36453356)
1. Is dacryocystectomy effective in reducing epiphora?
Alam MS; Kundu D
Indian J Ophthalmol; 2022 Dec; 70(12):4416-4418. PubMed ID: 36453356
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of dye disappearance test and tear meniscus height in diagnosis and postoperative assessment of nasolacrimal duct obstruction.
Roh JH; Chi MJ
Acta Ophthalmol; 2010 May; 88(3):e73-7. PubMed ID: 20546233
[TBL] [Abstract][Full Text] [Related]
3. Reliability of fluorescein dye disappearance test in assessment of adults with nasolacrimal duct obstruction.
Kashkouli MB; Mirzajani H; Jamshidian-Tehrani M; Pakdel F; Nojomi M; Aghaei GH
Ophthalmic Plast Reconstr Surg; 2013; 29(3):167-9. PubMed ID: 23503058
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of pyridostigmine (Mestinon) in the relief of patients with epiphora.
Yazicioglu T; Oklar M; İnan R
Photodiagnosis Photodyn Ther; 2023 Mar; 41():103240. PubMed ID: 36592783
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of probing for children with congenital nasolacrimal duct obstruction: a retrospective study using fluorescein dye disappearance test and lacrimal sac echography.
Steindler P; Mantovani E; Incorvaia C; Parmeggiani F
Graefes Arch Clin Exp Ophthalmol; 2009 Jun; 247(6):837-46. PubMed ID: 19107503
[TBL] [Abstract][Full Text] [Related]
6. Assessment of functional nasolacrimal duct obstruction--a survey of ophthalmologists in the southwest.
Cuthbertson FM; Webber S
Eye (Lond); 2004 Jan; 18(1):20-3. PubMed ID: 14707959
[TBL] [Abstract][Full Text] [Related]
7. Assessment of Lacrijet monocanalicular intubation for congenital nasolacrimal duct obstruction.
Hamed Azzam S; Hartstein M; Dolmetsch A; Mukari A
Eur J Ophthalmol; 2022 Nov; 32(6):3340-3345. PubMed ID: 35102761
[TBL] [Abstract][Full Text] [Related]
8. An investigation into the efficacy of probing the nasolacrimal duct as a treatment for epiphora in adults.
Bell TA
Trans Ophthalmol Soc U K (1962); 1986; 105 ( Pt 4)():494-7. PubMed ID: 3466472
[TBL] [Abstract][Full Text] [Related]
9. Nasal endoscopic features and outcomes of nasal endoscopy guided bicanalicular intubation for complex persistent congenital nasolacrimal duct obstructions.
Singh M; Sharma M; Kaur M; Grewal AM; Yadav D; Handa S; Yangzes S; Zadeng Z; Gupta P
Indian J Ophthalmol; 2019 Jul; 67(7):1137-1142. PubMed ID: 31238429
[TBL] [Abstract][Full Text] [Related]
10. Clinical efficacy comparison of low-temperature plasma radiofrequency ablation and Nd:YAG laser in treating recurrent acquired nasolacrimal duct obstruction.
Qin Q; Li B; Ming J; Liu B; Mou Y; Jin X
Lasers Med Sci; 2020 Dec; 35(9):1937-1944. PubMed ID: 32065299
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of tightening of orbicularis oculi muscle in patients with functional nasolacrimal duct obstruction.
Salour H; Khosravifard K; Bagheri A; Abrishami Y; Kheiri B; Tavakoli M
Orbit; 2016; 35(1):11-5. PubMed ID: 26646088
[TBL] [Abstract][Full Text] [Related]
12. Lacrimal and nasal masquerades of congenital nasolacrimal duct obstructions: etiology, management, and outcomes.
Kamal S; Ali MJ; Gupta A; Naik MN
Int Ophthalmol; 2015 Dec; 35(6):807-10. PubMed ID: 25680420
[TBL] [Abstract][Full Text] [Related]
13. Fluorescein Dye Disappearance Test: A Reliable Test in Assessment of Success After Dacryocystorhinostomy Procedure.
Kashkouli MB; Mirzajani H; Jamshidian-Tehrani M; Shahrzad S; Sanjari MS
Ophthalmic Plast Reconstr Surg; 2015; 31(4):296-9. PubMed ID: 25226097
[TBL] [Abstract][Full Text] [Related]
14. Management of functional epiphora in patients with an anatomically patent dacryocystorhinostomy.
Shams PN; Chen PG; Wormald PJ; Sloan B; Wilcsek G; McNab A; Selva D
JAMA Ophthalmol; 2014 Sep; 132(9):1127-32. PubMed ID: 24903661
[TBL] [Abstract][Full Text] [Related]
15. Outcome of External Dacryocystorhinostomy and Monocanalicular Intubation in Patients with Total Obstruction of One Canalicus.
Buttanri IB; Buttanri B; Serin D
Korean J Ophthalmol; 2019 Apr; 33(2):138-141. PubMed ID: 30977323
[TBL] [Abstract][Full Text] [Related]
16. Botulinum neurotoxin injection for the treatment of epiphora in nasolacrimal duct obstruction.
Girard B; Piaton JM; Keller P; Abadie C; Nguyen TH
J Fr Ophtalmol; 2017 Oct; 40(8):661-665. PubMed ID: 28847443
[TBL] [Abstract][Full Text] [Related]
17. Voluntary blinking and use of 0.25% dye on fluorescein dye disappearance test.
Kim C; Lee MJ; Khwarg SI
Can J Ophthalmol; 2013 Apr; 48(2):99-103. PubMed ID: 23561602
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of probing the nasolacrimal duct with adjunctive Mitomycin-C for epiphora in adults.
Tsai CC; Kau HC; Kao SC; Hsu WM; Liu JH
Ophthalmology; 2002 Jan; 109(1):172-4. PubMed ID: 11772600
[TBL] [Abstract][Full Text] [Related]
19. Silicone intubation with or without balloon dacryocystoplasty in acquired partial nasolacrimal duct obstruction.
Bleyen I; van den Bosch WA; Bockholts D; Mulder P; Paridaens D
Am J Ophthalmol; 2007 Nov; 144(5):776-780. PubMed ID: 17870048
[TBL] [Abstract][Full Text] [Related]
20. Silicone intubation for the treatment of epiphora in adults with presumed functional nasolacrimal duct obstruction.
Moscato EE; Dolmetsch AM; Silkiss RZ; Seiff SR
Ophthalmic Plast Reconstr Surg; 2012; 28(1):35-9. PubMed ID: 22262288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
